Lexicon Pharmaceuticals, Inc.
LXRX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$200 | -$177 | -$102 | -$88 |
| Dep. & Amort. | $1 | $1 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $13 | $14 | $12 | $11 |
| Change in WC | $14 | $3 | $0 | -$10 |
| Other Non-Cash | -$7 | -$2 | $1 | $0 |
| Operating Cash Flow | -$179 | -$162 | -$89 | -$87 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1 | -$0 | -$1 | -$1 |
| Net Acquisitions | $0 | $0 | $70 | -$3 |
| Inv. Purchases | -$338 | -$223 | -$134 | -$34 |
| Inv. Sales/Matur. | $314 | $174 | $64 | $38 |
| Other Inv. Act. | $9 | $0 | -$70 | $3 |
| Investing Cash Flow | -$15 | -$50 | -$71 | $2 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $50 | $49 | -$12 |
| Stock Issued | $0 | $139 | $94 | $37 |
| Stock Repurch. | -$2 | -$1 | -$1 | -$3 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $240 | $0 | $0 | $0 |
| Financing Cash Flow | $238 | $188 | $142 | $23 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $44 | -$24 | -$18 | -$62 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $22 | $46 | $64 | $126 |
| End Cash | $67 | $22 | $46 | $64 |
| Free Cash Flow | -$180 | -$162 | -$90 | -$88 |